These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14305344)

  • 1. STUDIES ON KILLED AND ATTENUATED MEASLES VACCINES IN GENERAL PRACTICE.
    WATSON GI
    Br Med J; 1965 Jul; 2(5452):13-6. PubMed ID: 14305344
    [No Abstract]   [Full Text] [Related]  

  • 2. KILLED MEASLES VACCINE PRIOR TO SEVEN MONTHS OF AGE FOLLOWED BY ATTENUATED LIVE VIRUS VACCINE AT NINE MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    Arch Gesamte Virusforsch; 1965; 16():343-6. PubMed ID: 14322891
    [No Abstract]   [Full Text] [Related]  

  • 3. CLINICAL AND SEROLOGICAL OBSERVATIONS ON THE CHILDREN GIVEN ATTENUATED MEASLES VACCINE.
    ARAI M; NAKAMURA M; AKAMATSU T; KIMURA M; KITAYAMA T; KOIDE G
    Acta Paediatr Jpn; 1963 Dec; 14():9-16. PubMed ID: 14200614
    [No Abstract]   [Full Text] [Related]  

  • 4. RESPONSE OF VOLTA CHILDREN TO JET INOCULATION OF COMBINED LIVE MEASLES, SMALLPOX AND YELLOW FEVER VACCINES.
    MEYER HM; HOSTETLER DD; BERNHEIN BC; ROGERS NG; LAMBIN P; CHASSARY A; LABUSQUIERE R; SMADEL JE
    Bull World Health Organ; 1964; 30(6):783-94. PubMed ID: 14215185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
    KIMURA M; ISHIGURO Y
    Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
    [No Abstract]   [Full Text] [Related]  

  • 6. OBSERVATIONS ON THE FURTHER ATTENUATION OF MEASLES VIRUS AND ON LIVE VACCINES PREPARED FROM HIGHLY ATTENUATED LINES OF VIRUS.
    CHU CM; KU YF; CHANG YH
    Chin Med J; 1964 Aug; 83():483-96. PubMed ID: 14174535
    [No Abstract]   [Full Text] [Related]  

  • 7. MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S
    Br Med J; 1965 Mar; 1(5438):813-7. PubMed ID: 14258844
    [No Abstract]   [Full Text] [Related]  

  • 8. VACCINATION OF INFANTS WITH LIVING ATTENUATED MEASLES VACCINE (EDMONSTON STRAIN) WITH AND WITHOUT GAMMA-GLOBULIN.
    BENSON PF; BUTLER NR; GOFFE AP; KNIGHT GJ; LAURENCE GD; MILLER CL; POLLOCK TM
    Br Med J; 1964 Oct; 2(5413):851-3. PubMed ID: 14185636
    [No Abstract]   [Full Text] [Related]  

  • 9. FURTHER OBSERVATIONS ON IMMUNIZATION WITH LIVE ATTENUATED MEASLES VIRUS VACCINE BY INHALATION.
    OKUNO Y
    Arch Gesamte Virusforsch; 1965; 16():294-9. PubMed ID: 14322881
    [No Abstract]   [Full Text] [Related]  

  • 10. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
    Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
    Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
    [No Abstract]   [Full Text] [Related]  

  • 12. FURTHER STUDY OF THE USE OF LIVE ATTENUATED MEASLES-VIRUS VACCINE.
    CHU FT; CHANG IH; SUNG HY; LING CC
    Paediatr Indones; 1964; 149():42-8. PubMed ID: 14279960
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on measles in Thailand. VI. A clinical trial of "CAM 70" measles virus vaccine in home-dwelling children.
    Sangkawibha N; Ueda S; Tuchinda P; Sakuntanaga P; Sunthonsaratul A
    Biken J; 1973 Dec; 16(4):167-71. PubMed ID: 4799209
    [No Abstract]   [Full Text] [Related]  

  • 14. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of extremely attenuated live measles virus vaccine (CAM-EX).
    Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
    Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
    [No Abstract]   [Full Text] [Related]  

  • 16. COMBINED USE OF HUMAN GAMMA-GLOBULIN AND LIVE MEASLES-VIRUS VACCINE WITH REFERENCE TO SINGLE INOCULATION OF LIVE MEASLES-VIRUS VACCINE IN EARLY INFANCY.
    FUJII R; MINAMITANI M; NAKAMURA K
    Jpn J Med Sci Biol; 1965 Feb; 18():56-64. PubMed ID: 14300295
    [No Abstract]   [Full Text] [Related]  

  • 17. MEASLES VACCINATION IN INFANTS. USE OF KILLED-LIVE COMBINATIONS.
    ALEXANDER ER; BANSMER CM; HARRIS ES; GILES B; SPARKS MJ
    Am J Dis Child; 1964 Nov; 108():470-8. PubMed ID: 14208407
    [No Abstract]   [Full Text] [Related]  

  • 18. CLINICAL TRIAL OF FURTHER ATTENUATED MEASLES VACCINE.
    BENSON PF; BUTLER NR
    Guys Hosp Rep; 1964; 113():349-53. PubMed ID: 14225140
    [No Abstract]   [Full Text] [Related]  

  • 19. MEASLES VACCINE FIELD TRIALS IN ALASKA. I. KILLED VACCINE FOLLOWED BY LIVE ATTENUATED VACCINE AND GAMMA-GLOBULIN WITH LIVE ATTENUATED VACCINE.
    BRODY JA; MCALISTER R; EMANUEL I; ALEXANDER ER
    JAMA; 1964 Aug; 189():339-42. PubMed ID: 14160504
    [No Abstract]   [Full Text] [Related]  

  • 20. Mumps vaccination.
    Hilleman MR
    Mod Trends Med Virol; 1970; 2(0):241-61. PubMed ID: 5527958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.